Amphotericin-B and Voriconazole for Pulmonary Blastomycosis

clinical trial

Details

Instance of: clinical trial
Start time: June 2015
End time: December 2018
Country: Canada
Main subject: blastomycosis
clinical trial phase: phase IV clinical trial
minimum age: 18
number of participants: 6
research intervention: amphotericin B
short name: BLASTO
sponsor: University of Manitoba
study type: interventional study
title: Case Series of Continuously-infused Amphotericin-B and Follow-up Voriconazole Therapy for Severe Blastomycosis Pulmonary Infections

Nothing in the MetaHistoryBook collection references this item yet.